JP2023182736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023182736A5 JP2023182736A5 JP2023173122A JP2023173122A JP2023182736A5 JP 2023182736 A5 JP2023182736 A5 JP 2023182736A5 JP 2023173122 A JP2023173122 A JP 2023173122A JP 2023173122 A JP2023173122 A JP 2023173122A JP 2023182736 A5 JP2023182736 A5 JP 2023182736A5
- Authority
- JP
- Japan
- Prior art keywords
- inventions described
- inventions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025119629A JP2025148537A (ja) | 2018-09-14 | 2025-07-16 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018173103 | 2018-09-14 | ||
| JP2018173103 | 2018-09-14 | ||
| JP2020546239A JP7407723B2 (ja) | 2018-09-14 | 2019-09-13 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
| PCT/JP2019/036239 WO2020054871A1 (ja) | 2018-09-14 | 2019-09-13 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546239A Division JP7407723B2 (ja) | 2018-09-14 | 2019-09-13 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025119629A Division JP2025148537A (ja) | 2018-09-14 | 2025-07-16 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023182736A JP2023182736A (ja) | 2023-12-26 |
| JP2023182736A5 true JP2023182736A5 (enExample) | 2024-03-12 |
| JP7715778B2 JP7715778B2 (ja) | 2025-07-30 |
Family
ID=69777862
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546239A Active JP7407723B2 (ja) | 2018-09-14 | 2019-09-13 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
| JP2023173122A Active JP7715778B2 (ja) | 2018-09-14 | 2023-10-04 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
| JP2025119629A Pending JP2025148537A (ja) | 2018-09-14 | 2025-07-16 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020546239A Active JP7407723B2 (ja) | 2018-09-14 | 2019-09-13 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025119629A Pending JP2025148537A (ja) | 2018-09-14 | 2025-07-16 | ヒト抗ｉｌ－３３モノクローナル抗体含有医薬用組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220041709A1 (enExample) |
| EP (1) | EP3851121A4 (enExample) |
| JP (3) | JP7407723B2 (enExample) |
| CN (3) | CN112739378B (enExample) |
| WO (1) | WO2020054871A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3088517B1 (en) | 2013-12-26 | 2023-11-01 | Mitsubishi Tanabe Pharma Corporation | Human anti-il-33 neutralizing monoclonal antibody |
| AU2018325645C1 (en) | 2017-08-31 | 2025-01-30 | Hyogo College Of Medicine | IL-33 antagonist-containing therapeutic agent for endometriosis |
| EP4149521A1 (en) * | 2020-05-11 | 2023-03-22 | MedImmune Limited | Formulations of anti-il-33 antibodies |
| CN113603775B (zh) | 2021-09-03 | 2022-05-20 | 江苏荃信生物医药股份有限公司 | 抗人白介素-33单克隆抗体及其应用 |
| CN113842457B (zh) * | 2021-11-04 | 2022-05-20 | 江苏荃信生物医药股份有限公司 | 包含抗人白介素-33单克隆抗体的液体制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5869046A (en) * | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US6171586B1 (en) * | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| WO2002079415A2 (en) * | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
| CN103458926B (zh) * | 2010-11-11 | 2016-10-26 | 艾伯维生物技术有限公司 | 改进的高浓度抗TNF α 抗体液体制剂 |
| JP6147726B2 (ja) * | 2011-03-29 | 2017-06-14 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ | タンパク質精製のためのバッファー系 |
| EP3088517B1 (en) | 2013-12-26 | 2023-11-01 | Mitsubishi Tanabe Pharma Corporation | Human anti-il-33 neutralizing monoclonal antibody |
| WO2016031932A1 (ja) * | 2014-08-27 | 2016-03-03 | 田辺三菱製薬株式会社 | アルカリ洗浄によるＦｃ領域を有するタンパク質の製造方法 |
| CN108064236B (zh) * | 2015-03-31 | 2021-12-10 | 免疫医疗有限公司 | 新颖的il33形式、il33的突变形式、抗体、测定及其使用方法 |
| JP6501650B2 (ja) * | 2015-06-25 | 2019-04-17 | 田辺三菱製薬株式会社 | ヒト抗ｉｌ−３３中和モノクローナル抗体 |
| EP3419599A4 (en) * | 2016-02-23 | 2019-09-11 | Sesen Bio, Inc. | IL-6 ANTAGONIST FORMULATIONS AND USE THEREOF |
| BR112019018022A2 (pt) * | 2017-03-01 | 2020-06-02 | Medimmune Limited | Formulações de anticorpos monoclonais |
| AU2018325645C1 (en) * | 2017-08-31 | 2025-01-30 | Hyogo College Of Medicine | IL-33 antagonist-containing therapeutic agent for endometriosis |
-
2019
- 2019-09-13 EP EP19860824.2A patent/EP3851121A4/en active Pending
- 2019-09-13 US US17/276,106 patent/US20220041709A1/en active Pending
- 2019-09-13 CN CN201980060117.XA patent/CN112739378B/zh active Active
- 2019-09-13 CN CN202510482161.7A patent/CN120267816A/zh active Pending
- 2019-09-13 WO PCT/JP2019/036239 patent/WO2020054871A1/ja not_active Ceased
- 2019-09-13 CN CN202510483754.5A patent/CN120267817A/zh active Pending
- 2019-09-13 JP JP2020546239A patent/JP7407723B2/ja active Active
-
2023
- 2023-10-04 JP JP2023173122A patent/JP7715778B2/ja active Active
-
2025
- 2025-07-16 JP JP2025119629A patent/JP2025148537A/ja active Pending